---
figid: PMC2861144__nihms195501f2
figtitle: Novel targets for the treatment of autosomal dominant polycystic kidney
  disease
organisms:
- Mus musculus
- Rattus norvegicus
- Bikinia letestui
- Tripterygium wilfordii
- Homo sapiens
- Canis lupus familiaris
- Streptomyces hygroscopicus
pmcid: PMC2861144
filename: nihms195501f2.jpg
figlink: /pmc/articles/PMC2861144/figure/F2/
number: F2
caption: PI3K converts the lipid PIP2 into PIP3 (Phosphatidylinositol (3,4,5)-trisphosphate),
  which localizes AKT to the membrane. The tuberous sclerosis complex 1 (TSC1; hamartin)
  and TSC2 (tuberin) complex is inactivated by AKT-dependent phosphorylation. Inactivation
  of TSC2 results in activation of mTOR via the Ras-related small GTPase (Rheb). mTOR
  phosphorylates p70S6K1, resulting in cell proliferation. mTOR inhibitors bind to
  FKBP (FK506 binding protein), which subsequently inhibits mTOR. There is evidence
  for activation of the mTOR pathway in ADPKD.
papertitle: Novel targets for the treatment of autosomal dominant polycystic kidney
  disease.
reftext: Franck A Belibi, et al. Expert Opin Investig Drugs. ;19(3):315-328.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9615816
figid_alias: PMC2861144__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Canis lupus familiaris
- Mus musculus
redirect_from: /figures/PMC2861144__F2
ndex: 257f838b-ded7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2861144__nihms195501f2.html
  '@type': Dataset
  description: PI3K converts the lipid PIP2 into PIP3 (Phosphatidylinositol (3,4,5)-trisphosphate),
    which localizes AKT to the membrane. The tuberous sclerosis complex 1 (TSC1; hamartin)
    and TSC2 (tuberin) complex is inactivated by AKT-dependent phosphorylation. Inactivation
    of TSC2 results in activation of mTOR via the Ras-related small GTPase (Rheb).
    mTOR phosphorylates p70S6K1, resulting in cell proliferation. mTOR inhibitors
    bind to FKBP (FK506 binding protein), which subsequently inhibits mTOR. There
    is evidence for activation of the mTOR pathway in ADPKD.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - TSC1
  - CCL26
  - RHEB
  - RHEBP1
  - TSC2
  - AKT1
  - AKT2
  - AKT3
  - IRS1
  - MTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RPS6KB1
  - RPS6KB2
  - Igf1
  - Tsc1
  - Rheb
  - Tsc2
  - Akt1
  - Irs1
  - Mtor
  - Pik3cg
  - Pik3r1
  - Fkbp1a
  - Rps6kb1
  - Temsirolimus
  - Sirolimus
---
